Vc - 2013 ((new))

One of the notable trends in 2013 was the emergence of mega-deals, which are investments exceeding $100 million. The report highlights that mega-deals accounted for 10% of the total VC investments in 2013, up from 7% in 2012. These large investments were primarily focused on companies in the technology, healthcare, and clean technology sectors.

Key features back then:

The year also saw a continued focus on the lasting impacts of pre-natal exposure to substances, providing critical data for pediatrics and public health policy. vc 2013

Windows Embedded and older Windows IoT images often have VC 2013 as the only modern(ish) C++ toolchain. One of the notable trends in 2013 was

The technology sector continued to dominate VC investments in 2013, accounting for 55% of the total investments. Within technology, sub-sectors like software, mobile, and e-commerce attracted significant attention from investors. Key features back then: The year also saw

A workshop held in Granada in September 2013 aimed to bridge the gap between low-grade inflammation and diet-related chronic conditions like Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD), emphasizing inflammation as a "friend and foe" in immunity.

The year 2013 was a pivotal moment in medical research, particularly in the fields of cancer care, nutritional science, and public health policy, often referenced as "VC 2013" in longitudinal studies and retrospective analyses. During this time, significant research was published in high-impact journals, focusing on enhancing survivorship care, understanding the biological bases of disease, and implementing novel treatments. Advances in Cancer Survivorship and Care